IN2012DN01878A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01878A IN2012DN01878A IN1878DEN2012A IN2012DN01878A IN 2012DN01878 A IN2012DN01878 A IN 2012DN01878A IN 1878DEN2012 A IN1878DEN2012 A IN 1878DEN2012A IN 2012DN01878 A IN2012DN01878 A IN 2012DN01878A
- Authority
- IN
- India
- Prior art keywords
- cancer
- diseases
- administration
- prevention
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000003642 reactive oxygen metabolite Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27575409P | 2009-09-02 | 2009-09-02 | |
| PCT/US2010/047615 WO2011028860A2 (en) | 2009-09-02 | 2010-09-02 | Compounds and compositions for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01878A true IN2012DN01878A (en) | 2015-08-21 |
Family
ID=43625764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1878DEN2012 IN2012DN01878A (en) | 2009-09-02 | 2010-09-02 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2473506A4 (en) |
| JP (1) | JP2013503888A (en) |
| KR (1) | KR20120104165A (en) |
| CN (1) | CN102625805A (en) |
| AU (1) | AU2010289493A1 (en) |
| BR (1) | BR112012004701A2 (en) |
| CA (1) | CA2772614A1 (en) |
| IN (1) | IN2012DN01878A (en) |
| WO (1) | WO2011028860A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101629642B1 (en) | 2014-06-25 | 2016-06-13 | 서울대학교산학협력단 | Food composition, pharmaceutical composition, animal medicine and feed composition against fatty liver with piperlongumine |
| GB201715008D0 (en) | 2017-09-18 | 2017-11-01 | Inst De Medicina Molecular Faculdade De Medicina Univ De Lisboa | TRPV2 Antagonists |
| KR102811108B1 (en) | 2018-12-27 | 2025-05-23 | 주식회사 티에스디라이프사이언스 | A pharmaceutical composition for treatment or prevention of biliary atresia comprising piperlongumine |
| CN110002987B (en) * | 2019-03-22 | 2020-09-15 | 南通大学 | Phenylallylidene cyclohexenone derivative, preparation method and use |
| CN117229205B (en) * | 2023-09-14 | 2025-03-21 | 中国医学科学院基础医学研究所 | Preparation method and pharmaceutical use of phenylacrylamide RHBDD1 inhibitor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080227829A1 (en) | 2007-02-14 | 2008-09-18 | Hammerstone John F | Neurogenic compounds |
| US20100093613A1 (en) * | 2007-03-09 | 2010-04-15 | Kunkel Eric J | Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| CN102146054A (en) * | 2010-02-10 | 2011-08-10 | 新昌县来益科技开发有限公司 | Piperlongumine derivatives and medicinal composition and application to preparation of medicament for inhibiting tumor growth thereof |
-
2010
- 2010-09-02 CA CA2772614A patent/CA2772614A1/en not_active Abandoned
- 2010-09-02 IN IN1878DEN2012 patent/IN2012DN01878A/en unknown
- 2010-09-02 EP EP10814469A patent/EP2473506A4/en not_active Withdrawn
- 2010-09-02 BR BR112012004701A patent/BR112012004701A2/en not_active IP Right Cessation
- 2010-09-02 JP JP2012528029A patent/JP2013503888A/en active Pending
- 2010-09-02 AU AU2010289493A patent/AU2010289493A1/en not_active Abandoned
- 2010-09-02 CN CN2010800418987A patent/CN102625805A/en active Pending
- 2010-09-02 KR KR1020127007113A patent/KR20120104165A/en not_active Withdrawn
- 2010-09-02 WO PCT/US2010/047615 patent/WO2011028860A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2473506A4 (en) | 2013-03-06 |
| KR20120104165A (en) | 2012-09-20 |
| JP2013503888A (en) | 2013-02-04 |
| AU2010289493A1 (en) | 2012-04-19 |
| CN102625805A (en) | 2012-08-01 |
| CA2772614A1 (en) | 2011-03-10 |
| WO2011028860A2 (en) | 2011-03-10 |
| BR112012004701A2 (en) | 2018-06-12 |
| WO2011028860A3 (en) | 2011-07-21 |
| EP2473506A2 (en) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
| MY157124A (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| PH12012501337A1 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
| WO2012024530A3 (en) | Therapeutic peptide-polymer conjugates, particles, compositions, and related methods | |
| EP4691558A3 (en) | Treatment or prophylaxis of proliferative conditions | |
| WO2011082267A3 (en) | Substituted triazolo-pyrazine compounds | |
| MX2011006959A (en) | Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds. | |
| SG10201811480WA (en) | Therapeutic compounds and compositions | |
| WO2011082266A3 (en) | Substituted heterocyclic compounds | |
| WO2010132697A3 (en) | Methods and compositions for treatment | |
| UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
| MY162903A (en) | Methods of treatment of pancreatic cancer | |
| MX394137B (en) | Novel compounds and compositions for targeting cancer stem cells | |
| IL207310A (en) | Vaccine compositions | |
| MX339862B (en) | Substituted imidazopyridinyl-aminopyridine compounds. | |
| GEP20156226B (en) | Compositions for treating centrally mediated nausea and vomiting | |
| WO2010059004A3 (en) | Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient | |
| WO2011123678A3 (en) | Substituted benzo-pyrido-triazolo-diazepine compounds | |
| WO2010097788A3 (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
| PH12012501556A1 (en) | Substituted naphthalenyl-pyrimidine compounds | |
| IN2012DN01878A (en) | ||
| MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
| NZ595440A (en) | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds | |
| PH12012500824A1 (en) | Oral composition for treating oral malodor | |
| WO2012061342A3 (en) | Substituted benzo-imidazo-pyrido-diazepine compounds |